Early stage IT and Healthcare Investing

Trius Therapeutics

portfoliocompanies

company snapshot

Trius Therapeutics

Trius Therapeutics (TSRX) is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections. The company is addressing the need for novel therapeutics to treat multi-drug-resistant bacterial infections as they become more resistant to currently marketed drugs. Trius was acquired by Cubist in 2013.

Facebook Google+ Twitter Email LinkedIn Share